OpenAI released the ChatGPT built-in tool Canvas. On December 11th, OpenAI launched the fourth day of technical live broadcast and released the latest function Canvas. According to reports, Canvas is directly built into ChatGPT, providing a separate window, which is mainly used for programming and writing tasks, providing opinions, reviewing and executing specific functions, and providing more detailed services. Simply put, Canvas is equivalent to a built-in Agent to help and guide ChatGPT to make better content generation and modification, and it is automatically triggered.More than 700 listed companies have announced the replacement of the audit institutions in 2024. According to incomplete statistics, since the beginning of this year, the number of listed companies planning to replace the accounting firms in 2024 has exceeded 700. Among them, the number of listed companies that intend to change accounting firms in October and November is 248 and 200 respectively. Looking back at the "exchange tide", three phenomena stand out: First, in order to improve the quality and ability of capital market intermediaries, the supervision of accounting firms by the regulatory authorities has been significantly enhanced. Based on the principle of prudence, listed companies collectively cancel the contract with the "problem institute"; Second, under the heavy penalty, more and more accountants choose to change their firms to practice, while listed companies choose to change their firms instead of accountants; Third, listed companies employ audit institutions through competitive negotiation, public bidding, invitation bidding, etc. In the bidding process, in order to attract more customers and increase the signing rate, the phenomenon of audit institutions reducing prices has increased. (Securities Daily)Huatai Securities: The expected recovery and fundamental stabilization of the real estate market are expected to accelerate under the policy blessing. Huatai Securities Research Report said that on December 9, the Political Bureau of the Central Committee held a meeting, stressing that it would "implement more active and promising macro policies" and pointed out that it would "stabilize the property market and stock market". Since the end of September, continuous favorable policies have supported fundamental improvement. The central government reiterated its support for real estate at key meetings, which means that there may be more room for policy support next year, and a more relaxed environment is expected to consolidate this improvement trend. The expected repair and fundamental stabilization of the real estate market are expected to accelerate under the blessing of policies. In the follow-up, we should still pay attention to the sustainability of market volume and price recovery and the progress of macro-support policies, purchasing and storage, urban village reconstruction and other policies. Before confirming the bottom of the market, we are more optimistic about housing enterprises with more resources and stable operation in core cities; At the same time, property management companies with resilient performance and stable cash flow are also expected to benefit from the market's stabilization.
New World Development sold Artisan Lab in Kowloon, Hong Kong for HK$ 620 million. Sing Tao Daily quoted an unnamed insider as saying that New World Development sold Artisan Lab in San Po Kong, Kowloon for HK$ 620 million. This 22-storey building was completed in 2022, with a floor area of about 120,000 square feet.Ministry of Finance of Korea: Korea's financial market is still facing uncertainty.Nippon Steel's share price rose by 1.2% shortly after the opening on Wednesday, and it is basically flat at present. In the news, US President Biden plans to formally prevent Nippon Steel from acquiring American steel companies for $14.1 billion. American steel stocks plunged overnight, once falling by 22%, and finally closed down by 9.7%.
Byte internal judges that the ceiling of AI dialogue products may not be high, so it is necessary to improve the priority of cutting and dreaming. It is learned from informed sources that Byte management judges that AI dialogue products (or chatbot products) may only be the "intermediate state" of AI products, and a more ideal product form for a long time requires a more visual user experience and a lower threshold for users to use. Therefore, Byte has promoted the product priority of Dreaming, and tried to create a "Tik Tok" in the AI era with a new path. In this regard, I asked the byte for verification, and the byte did not respond. (36Kr)Byte internal judges that the ceiling of AI dialogue products may not be high, so it is necessary to improve the priority of cutting and dreaming. It is learned from informed sources that Byte management judges that AI dialogue products (or chatbot products) may only be the "intermediate state" of AI products, and a more ideal product form for a long time requires a more visual user experience and a lower threshold for users to use. Therefore, Byte has promoted the product priority of Dreaming, and tried to create a "Tik Tok" in the AI era with a new path. In this regard, I asked the byte for verification, and the byte did not respond. (36Kr)Guotai Junan's annual strategy for innovative drugs in 2025: innovative pharmaceutical companies have accelerated into the harvest period, and the valuation has been at a historical low in the past five years. Guotai Junan said that the centralized purchasing policy has become stable, mature and normalized, and the marginal impact has weakened. Innovative drugs have gained policy inclination in the medical insurance negotiation. In the past two years, the policy has continued to promote pharmaceutical innovation, and the top-level design and local supporting chain support the development of innovative drugs. Commercial insurance is expected to bring new growth momentum to China's pharmaceutical market, and the overall industry trend is upward. At present, the trend of innovative drug industry is improving, the supply continues to accelerate, and a number of domestic innovative drugs are approved soon, which is expected to drive a new round of heavy volume. At the same time, the commercialization has achieved remarkable results and has occupied a dominant position in some sub-sectors. Pharma's performance continued to differentiate, and innovative drugs and just-needed drugs performed well. Biotech commercialization continues to increase, per capita yield continues to increase, the node of turning losses is approaching, and innovation ushers in the harvest period. Horizontal comparison: compared with overseas peers, the overall valuation of domestic innovative pharmaceutical companies is in a historically low range; Vertical comparison: the valuation of SW- pharmaceutical biology and SW- chemical preparations is at a historical low in the past five years, and it is expected that the valuation of subsequent sectors will pick up.
Strategy guide 12-13
Strategy guide
Strategy guide 12-13